The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab in pediatric participants with relapsed or refractory microsatellite instability-high solid tumors: Results from the phase 1/2 KEYNOTE-051 trial.
 
Alberto Pappo
Honoraria - Bayer; Lilly; Pfizer; Roche
Consulting or Advisory Role - Debbio; EUSA Pharma; Lilly; Loxo/Bayer; Merck; Pfizer
 
Hyoung Jin Kang
Consulting or Advisory Role - Amgen; GPCR Therapeutics; Jazz Pharmaceuticals; Novartis; Takeda
Research Funding - Amgen
Travel, Accommodations, Expenses - Takeda
 
Margaret Macy
Stock and Other Ownership Interests - GE Healthcare; Johnson & Johnson; Varian Medical Systems
Consulting or Advisory Role - EUSA Pharma; Kestrel Therapeutics; Kestrel Therapeutics; Ymabs Therapeutics Inc
Research Funding - Abbvie (Inst); Actuate Therapeutics (Inst); Bayer (Inst); Ignyta (Inst); Jubilant DraxImage (Inst); Lilly (Inst); Merck (Inst); Oncternal Therapeutics, Inc (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent for non-invasive methods of leukemia cell detection with MRI/MRS - Patent No. 8894975
Travel, Accommodations, Expenses - Bayer
(OPTIONAL) Uncompensated Relationships - Abbvie
 
Steven DuBois
Consulting or Advisory Role - Amgen; Bayer; EMD Serono; InhibRx; Jazz Pharmaceuticals
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Tanya Watt
Speakers' Bureau - Ymabs Therapeutics Inc
 
Claudia Rossig
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; Vertex
 
Luciana Vinti
Speakers' Bureau - Amgen; Takeda
Research Funding - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Amgen; Takeda
 
Robert Hayashi
Consulting or Advisory Role - Magenta Therapeutics
 
Kumudu Pathiraja
Employment - Merck
 
Rohini Singh
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Alexander Gozman
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Birgit Geoerger
Consulting or Advisory Role - AZD; Novartis; Roche/Genentech